InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.57
(
0.00%
)
US TECH 100
19,369.60
(
0.25%
)
Dow Jones
42,124.65
(
0.00%
)
Brent Oil
75.11
(
1.86%
)
Bitcoin
63,550.41
(
0.35%
)
Post# of 1850
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

MinnieM

Send PM Follow Ignore
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

MinnieM

Re: None

Friday, 09/16/2016 5:53:21 PM

Friday, September 16, 2016 5:53:21 PM

Post# of 1850
Does anyone have a link handy showing results of the ph II trial mentioned here?

http://axovant.com/clinical-trials/mindset-trial/

The MINDSET Phase 3 trial is designed to confirm the results of a 684-patient international, multi-center, double-blind placebo-controlled study in which patients on a stable background of donepezil therapy receiving 35 mg intepirdine demonstrated statistically significant improvements on the ADAS-cog and ADCS-ADL as compared to patients receiving donepezil alone.



I don't hold long or short, but, would like to understand the high valuation.


To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up